Commission publishes the EU Vaccines Strategy
On 17 June 2020 the Commission published communication COM(2020) 245, the EU Vaccines Strategy, and then negotiated advance purchase agreements intended to supply member states from a common portfolio. Delivery later occurred at scale after a slow start in early 2021. In the causal graph this event strengthens Public and donor investment in immunization systems, a driver that strengthens First-dose measles vaccination coverage (global, MCV1) — an improving welfare path.
Read the full account
On 17 June 2020 the Commission published communication COM(2020) 245, the EU Vaccines Strategy, and then negotiated advance purchase agreements intended to supply member states from a common portfolio. Delivery later occurred at scale after a slow start in early 2021. The strategy is a Commission administrative and contracting act under von der Leyen's presidency, implemented with the health commissioner and member-state steering.
Who was responsible
Contribution type and responsibility level for each recorded actor — not sole-author shorthand.
Ursula von der Leyen
PersonDirect responsibility
responsibility level 0.65 · verified
The President publicly owned joint procurement. Contracts were Commission acts. Clinical authorisation remained with EMA and supply with manufacturers, so responsibility is high but not exclusive.
What changed
Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.
- FactCommission publishes the EU Vaccines Strategy
- strengthensDriverPublic and donor investment in immunization systems
- strengthensIndicators (2)First-dose measles vaccination coverage (global, MCV1)
impact weight 0.65 · Effect from 17 June 2020 · verified
Central advance-purchase contracts increased public immunization investment and later dose availability in the Union, with a lag from signature to delivery and without converting COVID contracts into routine measles coverage by themselves.
Strengthens · Relationship strength 0.52 (weight 0.65 × strength 0.8)
Observed
84% of one-year-olds · 11 below the normal line (2024)
Worse than normal7 readings, 2018–2024: fell from 86.4% of one-year-olds to 84% of one-year-olds.
Above normal = better
Weakens · Relationship strength 0.39 (weight 0.65 × strength 0.6)
Observed
37.4 deaths per 1,000 live births · 12.4 above the normal line (2024)
Worse than normal7 readings, 2018–2024: fell from 40 deaths per 1,000 live births to 37.4 deaths per 1,000 live births.
Above normal = worse
Evidence
The sources behind this fact and its verification state.
- 1.European Court of Auditors — EU COVID-19 vaccine procurementEuropean Court of Auditors · High credibility · verified
- 2.COM(2020) 245 — EU Vaccines StrategyPublications Office of the European Union · High credibility · verified
Causal path
How this event connects to drivers and indicators in the graph.
- ActorUrsula von der Leyen
- contributed toFactCommission publishes the EU Vaccines Strategy
- strengthensDriverPublic and donor investment in immunization systems
- strengthensIndicatorFirst-dose measles vaccination coverage (global, MCV1)
Cite this page
Factrail. (2026). Commission publishes the EU Vaccines Strategy. Factrail. https://factrail.ai/facts/eu-vaccines-strategy-2020
https://factrail.ai/facts/eu-vaccines-strategy-2020
Accessed 15 October 2026.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute this factNamed here, or represent someone who is? Request a right of reply.